Eczema symptoms usually begin with dry, itchy skin that refuses to settle, and they look very different at six months old than they do at forty. Eczema is not one disease but a family of inflammatory skin conditions, and atopic dermatitis is by far the most common member of that family. It is chronic, it flares and calms, and it is not contagious. It is also far more treatable than most people realize, because fear of the treatments often does more damage than the treatments themselves.
In this article you will learn how to recognize eczema at different ages, how the main types differ, what causes it, and where blood tests genuinely help and where they mislead. You will also find a plain-language guide to using topical steroids correctly and an honest look at the newer injected and oral treatments.
What eczema is, and what it is not
Eczema describes skin that is inflamed, dry, itchy, and prone to cracking or oozing. The word is most often used interchangeably with atopic dermatitis, the long-running form that usually begins in childhood and runs in families with asthma and hay fever. Around one in ten American adults and one in five children live with some form of it. It is not an infection, so nobody catches it from a handshake or a swimming pool, and it has nothing to do with hygiene. It is not, strictly speaking, autoimmune either: the immune system overreacts to things outside the body rather than attacking the body’s own tissues.
The skin barrier, and the filaggrin story
Healthy skin works like a brick wall: flattened cells are the bricks, and a mix of fats and natural moisturizing factors is the mortar. A protein called filaggrin helps build both, squeezing skin cells into shape and then breaking down into the molecules that hold water in and keep the surface at the right acidity. Some people inherit changes in the filaggrin gene that reduce how much of it they make. These are found in a meaningful minority of people with atopic dermatitis of European ancestry, are much rarer in people of African ancestry, and tend to accompany eczema that starts early and persists longer. A weaker barrier lets water out and irritants, microbes, and allergens in, which is why moisturizing counts as treatment rather than pampering.
The immune side of the story
Once irritants get through, the immune system answers with signaling molecules, mainly interleukin-4, interleukin-13, and interleukin-31. These drive redness and swelling, and interleukin-31 acts on nerve endings to produce itch. Scratching then damages the barrier further. Breaking that itch-scratch loop is the goal of nearly every eczema treatment, and the most effective modern drugs block those exact signals.
Eczema symptoms at different ages
Infants
In babies under about two, eczema typically appears on the cheeks, scalp, and outer arms and legs, often weepy and crusted, while the diaper area is usually spared. Sleep disruption for the whole household is common and is a legitimate reason to seek treatment rather than wait.
Children
From roughly two years onward the pattern shifts into the skin creases: inner elbows, behind the knees, wrists, ankles, and neck. Skin there often turns thickened and leathery from months of rubbing, a change called lichenification. Darker or lighter marks left after a flare usually fade with time.
Adults
Adult eczema is often drier, scalier, and more localized. Hands, eyelids, neck, and nipples are typical sites, and hand eczema alone can be disabling for people who wash frequently at work. A first-ever rash of this kind after middle age deserves careful assessment, because other conditions imitate it closely.
The main types of eczema
Grouping everything under one label hides useful differences. Eczema symptoms overlap across the types, but the type changes what triggers a flare and what will clear it.
| Type | Typical appearance and site | What tends to drive it |
|---|---|---|
| Atopic dermatitis | Itchy, dry, inflamed patches in skin creases; usually starts in childhood | Inherited barrier weakness plus immune overactivity; family history of asthma or hay fever |
| Irritant contact dermatitis | Sore, chapped skin exactly where something touched, usually the hands | Repeated wet work, soaps, solvents; no allergy involved |
| Allergic contact dermatitis | Itchy, sometimes blistering rash a day or two after contact, often sharply bordered | A true delayed allergy to nickel, fragrance, preservatives, or poison ivy; found by patch testing |
| Dyshidrotic eczema | Crops of deep, intensely itchy blisters on palms, finger sides, and soles | Sweating, heat, stress, metal contact; recurs in episodes |
| Nummular eczema | Round, coin-shaped scaly plaques, often on lower legs and forearms | Very dry skin, winter air, minor injuries; often mistaken for ringworm |
| Seborrheic dermatitis | Greasy yellowish scale on scalp, eyebrows, sides of the nose, and chest | A reaction to normal skin yeast; needs antifungal shampoo, not moisturizer alone |
Two of these deserve separating. Irritant contact dermatitis is chemical damage and improves with protection and repair. Allergic contact dermatitis is an immune memory response that keeps returning until the culprit is identified and avoided, which is what patch testing is for. Adults whose eczema has stopped responding often turn out to have an added contact allergy, sometimes to a cream they were using to treat it.
Causes, triggers, and the atopic march
Eczema arises from an inherited tendency meeting an environment. Common flare triggers include soap and detergent, wool, dry indoor heating, temperature swings, sweat, dust mites, animal dander, pollen seasons, stress, and poor sleep. Hard water and long hot showers make barrier repair harder.
The atopic march
Doctors use the term atopic march for the tendency of allergic conditions to appear in sequence: eczema in infancy, then food allergy, then asthma, then hay fever. Current thinking is that a leaky skin barrier lets food proteins and airborne allergens meet the immune system before the gut has taught the body to tolerate them. This is a tendency, not a destiny. Allergic inflammation across these conditions can also raise eosinophil blood levels, though that finding on its own diagnoses nothing.
How eczema is diagnosed, and where lab tests fit
This is where a great deal of money and worry gets wasted, so it is worth being blunt. Eczema symptoms and their pattern are what make the diagnosis: a clinician looks at the skin, asks how the rash behaves, and takes a personal and family history. No blood test confirms eczema and none rules it out.
Why allergy panels mislead in eczema
Total immunoglobulin E is raised in many people with atopic dermatitis, but also in asthma, in parasite infections, and in plenty of people with nothing wrong at all. A high number says the immune system leans allergic; it does not say what to avoid and does not track how the skin is doing.
Specific immunoglobulin E panels and skin prick tests mislead more actively. They detect sensitization, meaning antibodies have been made against a food, and sensitization is very common in eczema without any real food reaction. A broad panel of dozens of foods in a child with eczema reliably produces several positives that mean nothing clinically. Families then remove milk, egg, wheat, and nuts. The eczema does not improve, growth can suffer, and removing a food the child previously tolerated risks creating a genuine, sometimes severe, allergy on reintroduction. Current American allergy guidance recommends against routine elimination diets in eczema for exactly that reason.
Targeted testing is different. If a child develops hives, vomiting, or swelling within minutes of eating a specific food, that history justifies testing for that food, interpreted by an allergist and sometimes confirmed by a supervised challenge. The test follows the story; the story does not follow the test. The same applies to food-specific antibody panels sold directly to consumers, which measure immunoglobulin G blood levels rather than allergy antibodies and are not a valid way to diagnose food intolerance.
When blood tests genuinely earn their place
There are three honest reasons a doctor orders bloodwork in eczema.
- Before and during systemic treatment, since anyone starting an oral immune-modifying drug needs baseline safety bloods and continued monitoring.
- Checking nutritional status when the picture warrants it. Low vitamin D has been linked with more severe eczema, and correcting a real deficiency is reasonable, though supplementing is not a cure. An unusual rash in an infant may prompt a zinc blood test, because zinc deficiency produces a rash around the mouth and diaper area that is often mistaken for eczema.
- Ruling out conditions that imitate eczema, which matters most when the presentation is atypical: adult onset, no family history of allergy, or a rash that ignores good treatment. An intensely itchy blistering rash on the elbows and knees can signal celiac disease. Persistent dry, scaly skin with fatigue and cold intolerance can point to an underactive thyroid, and a rash with joint pain and sun sensitivity raises different questions, for which a doctor may order an antinuclear antibody test.
Inflammation markers are checked when infection is suspected rather than to grade the eczema itself, and a doctor may then order a C-reactive protein level. A raised result there reflects the infection, not the rash.
Treatment, from moisturizer to injection
Emollients and bathing
Moisturizer is the foundation and stays in use even when skin looks clear. Thicker ointments hold water in better than lotions, and applying within a few minutes of a short lukewarm bath traps moisture. Use a fragrance-free non-soap cleanser, and expect to get through far more product than seems reasonable.
Topical corticosteroids, used properly
Fear of steroid creams is now one of the biggest obstacles to controlling eczema, and it produces the worst of both worlds: too little cream for too short a time, and months of low-grade inflammation. Used correctly, topical corticosteroids are among the best-studied and safest treatments in medicine. The key is matching potency to the site and using enough for long enough. American classification runs from group 1, the strongest, to group 7, the mildest, and thin skin absorbs more, so face, eyelids, and folds need mild preparations while palms and soles need strong ones.
| Potency group | Common examples | Where it is usually appropriate |
|---|---|---|
| Groups 1 and 2 (very strong) | Clobetasol propionate, betamethasone dipropionate ointment | Palms, soles, thickened stubborn patches; short courses under medical supervision |
| Groups 3 to 5 (moderate) | Triamcinolone acetonide, fluticasone propionate, mometasone furoate | Trunk, arms, and legs in adults and older children; the everyday workhorse strengths |
| Groups 6 and 7 (mild) | Desonide, hydrocortisone 1% and 2.5% | Face, eyelids, neck, armpits, groin, and infants |
One fingertip unit is the ribbon of ointment from an adult index fingertip to the first crease, and it covers about two adult palms. Apply once or twice daily until skin is smooth and no longer itchy, not merely until redness fades, which usually takes one to two weeks rather than two days. Once clear, applying the same steroid twice a week to sites that habitually flare reduces relapses without daily use.
The recognized risks are real but site-specific and dose-related: skin thinning, visible small blood vessels, and stretch marks, mainly from strong preparations used for months on thin skin. They are not the expected outcome of appropriate use. Needing potent steroids continuously to stay comfortable is not a reason to stop treating; it is a reason to ask about stepping up therapy.
Non-steroid topical options
Calcineurin inhibitors such as tacrolimus ointment and pimecrolimus cream calm inflammation without any risk of skin thinning, which makes them useful on eyelids, face, and folds; burning on first application is common and settles within a week. Newer non-steroid creams include crisaborole, ruxolitinib, and tapinarof, and wet wraps settle a severe flare quickly.
Phototherapy and systemic therapy
Narrowband ultraviolet B light therapy helps widespread eczema that topical treatment cannot control. When that is impractical, systemic treatment is next. Dupilumab, an injected antibody blocking the interleukin-4 and interleukin-13 signals, is approved in the United States down to six months of age; it does not suppress immunity broadly and needs no routine blood monitoring, and eye irritation is its characteristic side effect. Tralokinumab and lebrikizumab block interleukin-13 specifically, and nemolizumab targets the interleukin-31 pathway that drives itch.
Oral JAK inhibitors, upadacitinib and abrocitinib, work faster and often clear skin more completely, but demand more caution. As a class they carry a boxed warning covering serious infections, cardiovascular events, blood clots, and cancer, drawn largely from studies of an older drug in rheumatoid arthritis patients over fifty with heart risk factors. In practice that means screening and monitoring rather than avoidance. Doctors screen for tuberculosis and viral hepatitis and check baseline bloods before starting; follow-up visits repeat a lipid panel, recheck an alanine aminotransferase measurement, and track a complete blood count panel, since these drugs can lower lymphocyte counts and affect cholesterol and liver enzymes. Ciclosporin, methotrexate, and azathioprine remain in use and carry their own monitoring schedules.
Living with eczema, and when to see a doctor
Day-to-day management keeps eczema symptoms quiet and is unglamorous: fragrance-free products, cotton over wool, short cool showers, short nails, and treating the first hint of a flare rather than waiting. Sleep loss, anxiety, and low mood are genuine parts of the illness and worth raising with a clinician. For moderate to severe disease, dilute bleach baths twice weekly are sometimes advised to reduce bacterial load.
Eczema-affected skin carries more staphylococcus bacteria than healthy skin, so golden-yellow crusting, spreading warmth, pus, or a flare that suddenly stops responding all suggest infection. Book an appointment if the rash disturbs sleep or daily activities, if over-the-counter measures have failed after two weeks, if eczema keeps returning to the same site, or if a first-ever eczema-like rash appears in adulthood. Seek urgent care for a rapid eruption of small, uniform, punched-out sores with fever, which can mean a herpes virus is spreading across damaged skin, or for widespread red, painful, peeling skin.
Latest scientific advances
Comparing the newer drugs
A continuously updated review in JAMA Dermatology pooled the trials of every approved systemic treatment and compared them indirectly, since almost none have been tested head to head. The higher dose of one oral JAK inhibitor and the injected antibodies produced the largest improvements in rash and itch, with the meaningful differences lying in side effect profiles rather than in whether they work. A companion review in the Journal of Allergy and Clinical Immunology supplied the evidence base for the 2023 American allergy guidelines. What this means for you: if a first systemic drug does not suit you, several effective alternatives exist. A network meta-analysis, incidentally, ranks treatments never compared directly, so it carries less certainty than a head-to-head trial.
An independent look at value and safety
An independent health technology assessment reviewed abrocitinib, tralokinumab, and upadacitinib, confirmed all three clearly beat placebo, and noted that long-term safety data for the oral drugs were still maturing. What this means for you: the monitoring bloodwork attached to JAK inhibitors is not bureaucratic caution, it is how that remaining uncertainty is managed responsibly.
Diet, honestly assessed
A European task force reviewed the randomized trials of diets and supplements, including vitamins, minerals, probiotics, and prebiotics, in children who have eczema but no diagnosed food allergy. Across those trials the benefit for skin symptoms was small and inconsistent. What this means for you: without a clear food reaction, changing the diet is unlikely to clear the skin, and effort is better spent on moisturizing and anti-inflammatory treatment.
Pregnancy, and better maps of the biology
A 2025 review gathered the reports on women exposed to biologic treatment around conception or during pregnancy and found no signal of increased miscarriage or birth defects; it draws on case reports and registries rather than randomized trials, so it is still preliminary. Separately, reviews published in 2024 consolidated the picture of atopic dermatitis as several overlapping conditions rather than one. What this means for you: the pregnancy evidence is reassuring but belongs in a conversation with your obstetrician and dermatologist, and the biology work is the groundwork for choosing treatment by disease pattern rather than by trial and error.
Glossary
| Term | Definition |
|---|---|
| Atopic dermatitis | The most common form of eczema, a long-term inflammatory skin condition linked to a family tendency toward allergy. |
| Filaggrin | A skin protein that helps form the outer barrier and hold water in. Inherited reductions in it weaken the barrier. |
| Lichenification | Thickened, leathery skin with exaggerated surface lines, caused by long-term rubbing and scratching. |
| Atopic march | The tendency for eczema in infancy to be followed by food allergy, asthma, and hay fever in some children. |
| Sensitization | The presence of antibodies against a substance on a test, which does not by itself mean the person reacts to it. |
| Immunoglobulin E (IgE) | The antibody class involved in immediate allergic reactions. Often raised in eczema without pinpointing a cause. |
| Emollient | A moisturizing cream or ointment that softens skin and reduces water loss. The foundation of eczema care. |
| Fingertip unit | The ribbon of ointment from an adult fingertip to the first crease, enough to cover about two adult palms. |
| Biologic | An injected antibody-based drug that blocks one specific immune signal rather than suppressing immunity broadly. |
| JAK inhibitor | A tablet or cream that blocks Janus kinase enzymes, interrupting several inflammatory signals inside cells at once. |
Frequently asked questions
Is eczema contagious?
No. Eczema cannot pass from one person to another through touch, shared towels, swimming pools, or saliva. It results from an inherited tendency toward a weaker skin barrier combined with an overactive immune response to everyday exposures. The one exception to be aware of is that eczema-affected skin can become infected with bacteria or viruses, and those infections can be transmitted, which is another reason to get a suspected infection treated promptly.
Is eczema an autoimmune disease?
Not in the usual sense. In autoimmune diseases the immune system attacks the body’s own tissues. In eczema, the immune system overreacts to substances from outside the body that get through a weakened skin barrier. It is more accurate to call eczema an immune-mediated inflammatory skin condition. The distinction matters practically, because the treatments used for eczema target allergic-type inflammation rather than the pathways targeted in conditions such as lupus.
Is eczema genetic?
Partly. Having a parent or sibling with eczema, asthma, or hay fever substantially raises your chance of developing it, and inherited variations in barrier proteins such as filaggrin explain some of that risk. But genes are not the whole story: climate, water hardness, soap use, pollution, and early-life exposures all influence whether and how severely eczema appears. Two siblings carrying the same gene variant can have very different skin.
Can eczema be cured permanently?
There is no cure that removes the underlying tendency, but that is a less discouraging answer than it sounds. Many children see their eczema fade substantially by adolescence, and modern treatment can keep most adults essentially clear for long stretches. The realistic goal is sustained control with minimal flares, not eradication. Treating consistently rather than reactively is what makes the difference between an occasional nuisance and a constant problem.
Will a blood test tell me what food is causing my eczema?
Almost certainly not. Food allergy blood panels detect antibodies rather than reactions, and in people with eczema they commonly return positive results for foods that are perfectly well tolerated. Acting on those results usually leads to unnecessary dietary restriction without improving the skin. Testing is appropriate when there is a clear history of an immediate reaction to a specific food, and the results should be interpreted by an allergist alongside that history.
Are steroid creams safe for long-term use?
Used as directed, yes. Side effects such as skin thinning come mainly from strong preparations applied continuously for months to thin-skinned areas, not from appropriate intermittent use of the right strength. Applying too little for too short a time is the more common problem and leaves inflammation smoldering. If you are relying on a strong steroid week after week just to stay comfortable, discuss stepping up to a maintenance schedule or a different class of treatment rather than simply stopping.
Sources
- MedlinePlus, National Library of Medicine — Eczema — https://medlineplus.gov/eczema.html
- Mayo Clinic — Atopic dermatitis (eczema): symptoms and causes — https://www.mayoclinic.org/diseases-conditions/atopic-dermatitis-eczema/symptoms-causes/syc-20353273
- Cleveland Clinic — Eczema: types, symptoms and treatment — https://my.clevelandclinic.org/health/diseases/9998-eczema
- Drucker AM, Lam M, et al. — Systemic immunomodulatory treatments for atopic dermatitis: living systematic review and network meta-analysis update — JAMA Dermatology, 2024 — https://doi.org/10.1001/jamadermatol.2024.2192
- Chu AWL, Wong MM, et al. — Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials — Journal of Allergy and Clinical Immunology, 2023 — https://doi.org/10.1016/j.jaci.2023.08.029
- De Benedetto A, Boguniewicz M, et al. — Atopic dermatitis (eczema) guidelines 2023: highlights — Journal of Allergy and Clinical Immunology: In Practice, 2024 — https://doi.org/10.1016/j.jaip.2024.08.052
- Vassilopoulou E, Comotti A, et al. — Nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: an EAACI task force report — Allergy, 2024 — https://doi.org/10.1111/all.16160
- Edwards SJ, Karner C, et al. — Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis — Health Technology Assessment, 2024 — https://doi.org/10.3310/LEXB9006
- Sanchez-Garcia V, De-Miguel-Balsa E, et al. — Safety of dupilumab therapy for atopic dermatitis during pregnancy: a systematic review and meta-analysis — Acta Dermato-Venereologica, 2025 — https://doi.org/10.2340/actadv.v105.41307
- Criado PR, Miot HA, et al. — Update on the pathogenesis of atopic dermatitis — Anais Brasileiros de Dermatologia, 2024 — https://doi.org/10.1016/j.abd.2024.06.001
Further reading
- Persistent dry, scaly skin with fatigue and cold intolerance can raise the question of hypothyroidism symptoms and treatment
- A rash combined with joint pain and sun sensitivity may prompt a doctor to consider lupus symptoms and treatment options
- Repeated monitoring during systemic therapy often tracks lymphocyte blood test results
- People with long-term inflammation and poor iron status frequently review ferritin blood levels
- Anyone supplementing without seeing a change should read why vitamin D supplements sometimes fail
Understand your lab results with BloodSense
Eczema itself is diagnosed by looking at your skin, but bloodwork still shows up around it: safety checks before and during systemic treatment, vitamin D and zinc when nutrition is in question, and thyroid or celiac testing when a rash does not behave the way eczema should. Those reports arrive full of abbreviations and reference ranges that are easy to misread in either direction. BloodSense turns a blood, urine, or stool report into plain language so you arrive at your appointment knowing which numbers moved and which questions to ask. It helps you understand your results; it does not diagnose you and it does not replace your doctor.
